Intensifying Competition, Shorter Product Life Cycles and Substitute Products
First written in FY2016. 2 of 3 entries say "Reframed", first in FY2021. Latest entry: FY2024.
FUJIFILM Holdings moved to the "Worse" side of this theme in 2021, 4 years before the typical company in this theme (2025).
The whole theme swung hardest in 2026: 28 of 57 companies on the "Worse" side.
6 other companies' latest entry also says "Reframed".
- FY2024ReframedAnnual report
「In the Healthcare field, demand for biopharmaceuticals is expanding as treatments and preventive measures for cancer, rare diseases and emerging infectious diseases. The market for CDMO services, which contract the development of production processes and manufacturing, is expected to grow at an annual rate of 15% (Company estimate). At the same time, the Company identifies as major risks unpredictable, large-scale changes in healthcare administration policy resulting from healthcare system reforms; tighter regulations on medical devices; delays or cancellations of new drug development and changes in the business environment at pharmaceutical companies as drug discovery becomes more difficult; and intensifying competition in the market for contract process development and manufacturing of biopharmaceuticals due to technological innovation.」
The Company has organized competition and substitute-technology risks by business area, including Healthcare, Materials, Business Innovation and Imaging, rather than presenting them as general risks of intensifying competition. In Healthcare, it presents the CDMO market's expected annual growth of 15% alongside intensifying competition. - FY2021ReframedAnnual report
「In the Imaging field, business opportunities are expanding due to an increase in the number of images taken and growing demand for printing as smartphones become more widespread, growing demand for instant photography systems, and increased demand for lenses driven by the adoption of IoT and the shift to 4K and 8K video. At the same time, the Company identifies as risks intensifying competition in the high-end mirrorless digital camera market, intensifying competition in the high-performance industrial lens market as competitors improve their technologies, and improvements in smartphone camera performance.」
The Company has reorganized competition and substitute-product risks from general competitive risks into risks by business area, including mirrorless cameras, industrial lenses and smartphone cameras. - FY2016First statedAnnual report
「The Company may face lower unit selling prices due to intensifying competition with rival companies, shorter product life cycles and the emergence of substitute products.」
The Company indicates that price declines, shorter product life cycles and the emergence of substitute products could affect sales, profits and research and development expenses.